Kennedy's surgery may be followed by experimental therapy

Legendary Duke neurosurgeon Dr. Allan Friedman is scheduled to remove Senator Ted Kennedy's brain tumor this morning, and there's already significant speculation that the lawmaker will undergo experimental therapy in a follow-up treatment. According to a statement, the Duke neurosurgeon will surgically remove the tumor and the senator will undergo radiation and chemotherapy to combat the glioblastoma. About half of all glioblastoma patients die within a year of surgery. Median survival time is 12 to 15 months.

Kennedy, though, is in the hands of the countries best neuro-oncologists. In addition to the chemo drug Temodar, Kennedy may be treated with Avastin. While approved for other cancers, using Avastin to starve the tumor of blood is still only in the experimental stage for brain tumors.

- read the AP report

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.